Consistent with a critical role for peri-implantation Treg cells, a genetic model of preeclampsia involving overexpression of human angiotensinogen and renin in rats showed greater responsiveness to Treg cell therapy when it was applied in early gestation (122). The gene discussed is AGT; the disease is preeclampsia.